维普期刊资源整合服务平台（V6.5）

53篇 您的检索式：作者名="KAERN J"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer: the Nordic experience显示文摘	Trope C Hogberg T Kaern J	1998	Ann Oncol1998，9，12：	2
2	Stochasticity in gene expression: from theories to phenotypes 显示文摘	KAERN M ELSTON T BLAKE WJ COLLINS J J	2005	Nature Reviews Genetics2005，6，：	1
3	Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument显示文摘	Trope C Kaern J Hogberg T	2000	Ann Oncol2000，11，3：	1
4	HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumor, and solid metastases显示文摘	HETLAND TE HOLTH A KAERN J	2012	Virchows Archiv2012，460，5：	1
5	Tamoxifen in the treatment of recurrent ovarian carcinoma显示文摘	Marth C Sorbeim N Kaern J	1997	Int J Gynecol Cancer1997，7，：	1
6	Are borderline tumors of the ovary overtreated both surgically and systemically? A review of four prospective randomized trials including 253 patients with borderline tumors显示文摘	Trop C Kaern J Vergote IB	1993	Gynecol Oncol1993，51，2：	1
7	Adjuvant chemotherapy for early-stage ovarian cancer: review of the literature 显示文摘	TROPE C KAERN J	2007	J Clin Oncol2007，25，20：	1
8	A phase Ⅱ study of 5-fluorouracil/cisplatinum in recurrent cervical cancer 显示文摘	Kaern J Trop C Abeler V	1990	Acta Oncol1990，29，1：	1
9	Long-term follow-up of neoadju- rant cisplatin and 5-fluorouracil chemotherapy in bulky squamous cell carcinoma of the cervix 显示文摘	Marth C Sundfor K Kaern J	1999	Acta Oncol1999，38，4：	1
10	Chemotherapy versus hormonal treatment in patients with platinum and taxane resistant ovarian cancer: a NS(;O study 显示文摘	Kristensen G Kaern J Baekelandt M	2008	Clin Oncol2008，26，155：	1
11	Borderline ovarian tumors显示文摘	Tropé C G Kaern J Davidson B	2012	Best Pract Res Clin Obstet Gynaecol2012，26，3：	1
12	Stochasticity in gene expression:from theories to phenotypes 显示文摘	Kaern M Elston T C Blake W J	2005	Nat Rev C enet2005，6，6：	1
13	Malignant Melanoma of Vulva FIGO Stage I: Evaluation of Prognostic Factors in 43Patients With Emphasis on DNA Ploidy and Surgical Treatment 显示文摘	Scheistroen M Trope C Kaern J	1996	Gynecol Oncol1996，61，：	1
14	DNA ploidy and expression of p53 and C-erbB-2 in extramammary Paget's disease of the vulva显示文摘	Scheistroen M Trope C Kaern J et a1	1997	Gynecol Oncol1997，64，1：	1
15	Cellular DNA content as a new prognostic tool in patients with borderline tumors of the ovary显示文摘	Kaern J Trope C Kjorstad KE		0，，03：	1
16	Prognostic value ofpre-and postoperative serum CA-125 levels in ovarian cancer:new aspects and multivariate analysis显示文摘	Makar AP Kristensen GB Kaern J	1992	Obstet Gynecol1992，79，：	1
17	Kallikrein 4 Is Associated with Paclitaxel Resistance in Ovarian Cance显示文摘	Xi Z Kaern J Davidson B	2004	Gynecologic Ontol- ogy2004，94，1：	1
18	HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumors, and solid me- tastases显示文摘	Hetland TE Holth A Kaern J	2012	Virchows Arch2012，460，5：	1
19	The engineering of gene regulatory networks显示文摘	Kaern M Blake W J Collins J J	2003	Annual Review of Biomedical Engineering2003，5，：	1
20	Effects of paclitaxel on CA125 serum levels in ovarian cancer patients显示文摘	Paulsen T Marth C Kaern J	2000	Gynecol Oncol2000，76，3：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示